Publicaciones en las que colabora con Esteban Daudén Tello (10)

2024

  1. Genetic polymorphisms to identify patients with an optimal response to tildrakizumab in psoriasis patients from real-life clinical practice

    Experimental Dermatology, Vol. 33, Núm. 8

2021

  1. Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study

    Journal of Allergy and Clinical Immunology, Vol. 147, Núm. 1, pp. 60-71

2017

  1. Prevalence of amyloid deposits determined by fine-needle aspiration of abdominal fat in patients with psoriasis

    Journal of the European Academy of Dermatology and Venereology

2010

  1. Leishmaniasis y nodulosis reumatoide en paciente con infección por el virus de la inmunodeficiencia humana

    Actas Dermo-Sifiliograficas, Vol. 101, Núm. 2, pp. 164-167

  2. Therapeutic drug monitoring of mycophenolic acid in patients with psoriasis

    European Journal of Dermatology, Vol. 20, Núm. 3, pp. 321-322

2006

  1. Sequential study on the treatment of moderate-to-severe chronic plaque psoriasis with mycophenolate mofetil and cyclosporin

    Journal of the European Academy of Dermatology and Venereology, Vol. 20, Núm. 6, pp. 702-706

2005

  1. Ross syndrome, an entity included within the spectrum of partial disautonomic syndromes

    Journal of the European Academy of Dermatology and Venereology, Vol. 19, Núm. 6, pp. 729-731

  2. Systemic amyloidoses

    Actas Dermo-Sifiliograficas, Vol. 96, Núm. 2, pp. 69-82

2003

  1. Epidermodysplasia verruciformis-like lesions in a patient with systemic lupus erythematosus [5]

    Acta Dermato-Venereologica

1994

  1. SANDIMMUN® (CICLOSPORINA A) EN PSORIASIS CRONICA SEVERA. RESULTADOS DEL ESTUDIO MULTICENTRICO ESPANOL

    Actas Dermo-Sifiliograficas, Vol. 85, Núm. 5, pp. 381-385